CHICAGO–(BUSINESS WIRE)–CerroZone™ LLC’s new mobile air purification device has earned 510(k) Class II clearance from the U.S. Food and Drug Administration as a recirculating air cleaner for eliminating airborne viruses and bacteria. The FDA approval was contingent on extensive testing at accredited independent third-party facilities. The CerroZone mobile unit is designed to purify air in … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Surgical Devices Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmology Surgical Devices Market is anticipated to grow with a CAGR of nearly 5.5% during the forecast period. The major factors driving the growth of the market are the global prevalence of … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Human Microbiome Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Human Microbiome Market is projected to reach USD 3,724.81 million by 2027 from USD 1,053.28 million in 2021, at a CAGR 23.43% during the forecast period. Market Statistics: The report provides market sizing and … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Burns – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report deliver an in-depth understanding of the Burns historical and forecasted epidemiology as well as the Burns market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The … [Read more…]
Hire follows Cleerly’s $223 million Series C and furthers value-based care business strategy NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Joseph “Joe” Jasser, MD, as chief of value based care. In this role, Dr. Jasser will be responsible for developing and executing the initial … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Transfection Reagents & Equipment Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Transfection Reagents & Equipment Market is projected to reach USD 4,004.73 million by 2027 from USD 1,967.91 million in 2021, at a CAGR 12.57% during the forecast period. Market Statistics: The report … [Read more…]
–Company Advances Product Candidate Pipeline— –Announces Preliminary Results from Virology Study– BERWYN, Pa.–(BUSINESS WIRE)–#earnings—Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing non-addictive product candidates for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced its financial results for the quarter ended June 30, … [Read more…]
VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) announces it has signed a licensing partnership agreement with Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’) to implement their KARE® protocol for those suffering from Alcohol Use Disorder seeking sustained recovery measures focused … [Read more…]
Outset’s Tablo® Hemodialysis System to become more widely available to veterans through a national contract with the United States Department of Veterans Affairs. SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”) announced today that the Strategic Acquisition Center (SAC) Office of Procurement, Department of Veterans Affairs awarded a national contract that enables the company’s … [Read more…]
VIENNA, Va.–(BUSINESS WIRE)–$CVM #Multikine–CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2022, as well as key clinical and corporate developments. Clinical and Corporate Developments include: The American Society of Clinical Oncology (ASCO) published two abstracts related to CEL-SCI’s pivotal randomized controlled Phase 3 Multikine® (Leukocyte Interleukin, Injection)* head … [Read more…]
